DOSE REDUCTION OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY: A PILOT STUDY

被引:0
|
作者
van Herwaarden, N. [1 ]
Herfkens-Hol, S. [1 ]
van der Maas, A. [1 ]
van den Bemt, B. [1 ]
van Vollenhoven, R. [2 ]
Bijlsma, J. [3 ]
den Broeder, A. [1 ]
机构
[1] Sint Maartensklin, Nijmegen, Netherlands
[2] Karolinska Inst, ClinTRID, Stockholm, Sweden
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:886 / 886
页数:1
相关论文
共 50 条
  • [41] RELATIONSHIP BETWEEN SERUM CONCENTRATIONS OF CYTOKINES AND DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Mitsui, H.
    Yoshikawa, K.
    Nagaya, Y.
    Otsuka, T.
    Mitsui, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 483 - 483
  • [42] Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience
    Oscar Epis
    Cinzia Casu
    Laura Belloli
    Emanuela Schito
    Davide Filippini
    Marina Muscarà
    Eleonora Bruschi
    Rheumatology International, 2015, 35 : 1569 - 1570
  • [43] Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience
    Epis, Oscar
    Casu, Cinzia
    Belloli, Laura
    Schito, Emanuela
    Filippini, Davide
    Muscara, Marina
    Bruschi, Eleonora
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (09) : 1569 - 1570
  • [44] DOSE REDUCTION OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS ACHIEVING SUSTAINED DISEASE CONTROL: RESULTS OF A PROSPECTIVE STUDY
    Takeuchi, T.
    Genovese, M. C.
    Haraoui, B.
    Li, Z.
    Xie, L.
    Klar, R.
    Correia, A. P.
    Otawa, S.
    Lopez-Romero, P.
    De la Torre, I.
    Rooney, T.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 988 - 989
  • [45] Dose Reduction of Baricitinib in Patients with Rheumatoid Arthritis Achieving Sustained Disease Control: Results of a Prospective Study
    Takeuchi, Tsutomu
    Genovese, Mark C.
    Haraoui, Boulos
    Li, Zhanguo
    Xie, Li
    Klar, Rena
    Correia, Ana Pinto
    Otawa, Susan
    Lopez-Romero, Pedro
    de la Torre, Inmaculada
    Rooney, Terence P.
    Smolen, Josef S.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [46] Dose Reduction of Baricitinib in Patients with Rheumatoid Arthritis Achieving Sustained Disease Control: Results of a Prospective Study
    Takeuchi, Tsutomu
    Genovese, Mark
    Haraoui, Boulos
    Li, Zhanguo
    Xie, Li
    Klar, Rena
    Correia, Ana Pinto
    Otawa, Susan
    Lopez-Romero, Pedro
    de la Torre, Inmaculada
    Rooney, Terence
    Smolen, Josef
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1054 - 1054
  • [47] Dose Reduction of Baricitinib in Patients with Rheumatoid Arthritis Achieving Sustained Disease Control: Results of a Prospective Study
    Takeuchi, Tsutomu
    Genovese, Mark
    Haraoui, Boulos
    Li, Zhanguo
    Xie, Li
    Klar, Rena
    Correia, Ana
    Otawa, Susan
    Lopez-Romero, Pedro
    de la Torre, Inmaculada
    Rooney, Terence
    Smolen, Josef
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 807 - 808
  • [48] Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study
    Takeuchi, Tsutomu
    Genovese, Mark C.
    Haraoui, Boulos
    Li, Zhanguo
    Xie, Li
    Klar, Rena
    Pinto-Correia, Ana
    Otawa, Susan
    Lopez-Romero, Pedro
    de la Torre, Inmaculada
    Macias, William
    Rooney, Terence P.
    Smolen, Josef S.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (02) : 171 - 178
  • [49] DOSE REDUCTION OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS ACHIEVING SUSTAINED DISEASE CONTROL: RESULTS OF A PROSPECTIVE STUDY
    Takeuchi, T.
    Genovese, M.
    Haraoui, B.
    Xie, L.
    Klar, R.
    Correia, A. Luisa Pinto
    Rooney, T.
    Otawa, S.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 795 - 796
  • [50] THE EFFECTS OF VERY LOW DOSE PREDNISOLONE GIVEN AT NIGHT - A PILOT STUDY IN RHEUMATOID ARTHRITIS
    Kirwan, J. R.
    Roberts, C. M.
    Harbuz, M. S.
    Jessop, D. S.
    RHEUMATOLOGY, 2002, 41 : 96 - 97